Gradient Capital Advisors LLC increased its position in shares of Dimensional U.S. Targeted Value ETF (NYSEARCA:DFAT – Get Rating) by 30.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 145,910 shares of the company’s stock after acquiring an additional 33,930 shares during the quarter. Dimensional U.S. Targeted Value ETF comprises about 2.7% of Gradient Capital Advisors LLC’s investment portfolio, making the stock its 10th largest position. Gradient Capital Advisors LLC owned approximately 0.09% of Dimensional U.S. Targeted Value ETF worth $5,686,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Venture Visionary Partners LLC bought a new stake in Dimensional U.S. Targeted Value ETF in the second quarter valued at about $25,000. GPS Wealth Strategies Group LLC bought a new stake in Dimensional U.S. Targeted Value ETF in the second quarter valued at about $28,000. Steph & Co. bought a new stake in Dimensional U.S. Targeted Value ETF in the third quarter valued at about $32,000. McClarren Financial Advisors Inc. bought a new stake in Dimensional U.S. Targeted Value ETF in the third quarter valued at about $40,000. Finally, Bogart Wealth LLC bought a new stake in Dimensional U.S. Targeted Value ETF in the third quarter valued at about $40,000.
Dimensional U.S. Targeted Value ETF Trading Down 0.9 %
NYSEARCA DFAT traded down $0.40 on Wednesday, reaching $46.40. The company had a trading volume of 9,094 shares, compared to its average volume of 235,081. Dimensional U.S. Targeted Value ETF has a 52 week low of $38.59 and a 52 week high of $48.22. The stock’s 50 day moving average is $45.28 and its 200-day moving average is $43.71.
Featured Articles
- Get a free copy of the StockNews.com research report on Dimensional U.S. Targeted Value ETF (DFAT)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Want to see what other hedge funds are holding DFAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dimensional U.S. Targeted Value ETF (NYSEARCA:DFAT – Get Rating).
Receive News & Ratings for Dimensional U.S. Targeted Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dimensional U.S. Targeted Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.